子宮がん診断検査の世界市場（～2026年）

• 英文タイトル：Global Uterine Cancer Diagnostic Testing Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04959
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療機器・消耗品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は子宮がん診断検査のグローバル市場について調査・分析したレポートです。種類別（超音波スキャン、生検手順、血液検査）市場規模、用途別（病院、外来外科センター、がん研究所、専門クリニック、診断研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別子宮がん診断検査の競争状況、市場シェア
・世界の子宮がん診断検査市場：種類別市場規模 2015年-2020年（超音波スキャン、生検手順、血液検査）
・世界の子宮がん診断検査市場：種類別市場規模予測 2021年-2026年（超音波スキャン、生検手順、血液検査）
・世界の子宮がん診断検査市場：用途別市場規模 2015年-2020年（病院、外来外科センター、がん研究所、専門クリニック、診断研究所、その他）
・世界の子宮がん診断検査市場：用途別市場規模予測 2021年-2026年（病院、外来外科センター、がん研究所、専門クリニック、診断研究所、その他）
・北米の子宮がん診断検査市場分析：米国、カナダ
・ヨーロッパの子宮がん診断検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの子宮がん診断検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の子宮がん診断検査市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの子宮がん診断検査市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Abbott、Roche Holdings、Siemens、Danaher、BioMerieux
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Uterus a female organ also referred as the womb is located in the lower abdomen. It supports in the fetal development until birth.
In North America, the U.S. is expected to be the dominant market for uterine cancer diagnostic testing due to growing incidence of uterine cancer.

Market Analysis and Insights: Global Uterine Cancer Diagnostic Testing Market
The global Uterine Cancer Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Uterine Cancer Diagnostic Testing Scope and Market Size
Uterine Cancer Diagnostic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Uterine Cancer Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Abbott
Roche Holdings
Siemens
Danaher
BioMerieux
…

Market segment by Type, the product can be split into
Ultrasound Scanning
Biopsy Procedures
Blood Tests
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Cancer Research Institutes
Specialized Clinics
Diagnostic Laboratories
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Uterine Cancer Diagnostic Testing Revenue
1.4 Market by Type
1.4.1 Global Uterine Cancer Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ultrasound Scanning
1.4.3 Biopsy Procedures
1.4.4 Blood Tests
1.5 Market by Application
1.5.1 Global Uterine Cancer Diagnostic Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Cancer Research Institutes
1.5.5 Specialized Clinics
1.5.6 Diagnostic Laboratories
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Uterine Cancer Diagnostic Testing Market Perspective (2015-2026)
2.2 Global Uterine Cancer Diagnostic Testing Growth Trends by Regions
2.2.1 Uterine Cancer Diagnostic Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Uterine Cancer Diagnostic Testing Historic Market Share by Regions (2015-2020)
2.2.3 Uterine Cancer Diagnostic Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Uterine Cancer Diagnostic Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Uterine Cancer Diagnostic Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Uterine Cancer Diagnostic Testing Players by Market Size
3.1.1 Global Top Uterine Cancer Diagnostic Testing Players by Revenue (2015-2020)
3.1.2 Global Uterine Cancer Diagnostic Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Uterine Cancer Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Uterine Cancer Diagnostic Testing Market Concentration Ratio
3.2.1 Global Uterine Cancer Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Uterine Cancer Diagnostic Testing Revenue in 2019
3.3 Uterine Cancer Diagnostic Testing Key Players Head office and Area Served
3.4 Key Players Uterine Cancer Diagnostic Testing Product Solution and Service
3.5 Date of Enter into Uterine Cancer Diagnostic Testing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Uterine Cancer Diagnostic Testing Historic Market Size by Type (2015-2020)
4.2 Global Uterine Cancer Diagnostic Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020)
5.2 Global Uterine Cancer Diagnostic Testing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Uterine Cancer Diagnostic Testing Market Size (2015-2020)
6.2 Uterine Cancer Diagnostic Testing Key Players in North America (2019-2020)
6.3 North America Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020)
6.4 North America Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020)

7 Europe
7.1 Europe Uterine Cancer Diagnostic Testing Market Size (2015-2020)
7.2 Uterine Cancer Diagnostic Testing Key Players in Europe (2019-2020)
7.3 Europe Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020)
7.4 Europe Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020)

8 China
8.1 China Uterine Cancer Diagnostic Testing Market Size (2015-2020)
8.2 Uterine Cancer Diagnostic Testing Key Players in China (2019-2020)
8.3 China Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020)
8.4 China Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020)

9 Japan
9.1 Japan Uterine Cancer Diagnostic Testing Market Size (2015-2020)
9.2 Uterine Cancer Diagnostic Testing Key Players in Japan (2019-2020)
9.3 Japan Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020)
9.4 Japan Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Uterine Cancer Diagnostic Testing Market Size (2015-2020)
10.2 Uterine Cancer Diagnostic Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020)

11 India
11.1 India Uterine Cancer Diagnostic Testing Market Size (2015-2020)
11.2 Uterine Cancer Diagnostic Testing Key Players in India (2019-2020)
11.3 India Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020)
11.4 India Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Uterine Cancer Diagnostic Testing Market Size (2015-2020)
12.2 Uterine Cancer Diagnostic Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020)
12.4 Central & South America Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Uterine Cancer Diagnostic Testing Introduction
13.1.4 Abbott Revenue in Uterine Cancer Diagnostic Testing Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Roche Holdings
13.2.1 Roche Holdings Company Details
13.2.2 Roche Holdings Business Overview
13.2.3 Roche Holdings Uterine Cancer Diagnostic Testing Introduction
13.2.4 Roche Holdings Revenue in Uterine Cancer Diagnostic Testing Business (2015-2020)
13.2.5 Roche Holdings Recent Development
13.3 Siemens
13.3.1 Siemens Company Details
13.3.2 Siemens Business Overview
13.3.3 Siemens Uterine Cancer Diagnostic Testing Introduction
13.3.4 Siemens Revenue in Uterine Cancer Diagnostic Testing Business (2015-2020)
13.3.5 Siemens Recent Development
13.4 Danaher
13.4.1 Danaher Company Details
13.4.2 Danaher Business Overview
13.4.3 Danaher Uterine Cancer Diagnostic Testing Introduction
13.4.4 Danaher Revenue in Uterine Cancer Diagnostic Testing Business (2015-2020)
13.4.5 Danaher Recent Development
13.5 BioMerieux
13.5.1 BioMerieux Company Details
13.5.2 BioMerieux Business Overview
13.5.3 BioMerieux Uterine Cancer Diagnostic Testing Introduction
13.5.4 BioMerieux Revenue in Uterine Cancer Diagnostic Testing Business (2015-2020)
13.5.5 BioMerieux Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Uterine Cancer Diagnostic Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Uterine Cancer Diagnostic Testing Revenue
Table 3. Ranking of Global Top Uterine Cancer Diagnostic Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Uterine Cancer Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ultrasound Scanning
Table 6. Key Players of Biopsy Procedures
Table 7. Key Players of Blood Tests
Table 8. Global Uterine Cancer Diagnostic Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Uterine Cancer Diagnostic Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Uterine Cancer Diagnostic Testing Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Uterine Cancer Diagnostic Testing Market Share by Regions (2015-2020)
Table 12. Global Uterine Cancer Diagnostic Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Uterine Cancer Diagnostic Testing Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Uterine Cancer Diagnostic Testing Market Growth Strategy
Table 18. Main Points Interviewed from Key Uterine Cancer Diagnostic Testing Players
Table 19. Global Uterine Cancer Diagnostic Testing Revenue by Players (2015-2020) (Million US$)
Table 20. Global Uterine Cancer Diagnostic Testing Market Share by Players (2015-2020)
Table 21. Global Top Uterine Cancer Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Cancer Diagnostic Testing as of 2019)
Table 22. Global Uterine Cancer Diagnostic Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Uterine Cancer Diagnostic Testing Product Solution and Service
Table 25. Date of Enter into Uterine Cancer Diagnostic Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 28. Global Uterine Cancer Diagnostic Testing Market Size Share by Type (2015-2020)
Table 29. Global Uterine Cancer Diagnostic Testing Revenue Market Share by Type (2021-2026)
Table 30. Global Uterine Cancer Diagnostic Testing Market Size Share by Application (2015-2020)
Table 31. Global Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 32. Global Uterine Cancer Diagnostic Testing Market Size Share by Application (2021-2026)
Table 33. North America Key Players Uterine Cancer Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Uterine Cancer Diagnostic Testing Market Share (2019-2020)
Table 35. North America Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 36. North America Uterine Cancer Diagnostic Testing Market Share by Type (2015-2020)
Table 37. North America Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 38. North America Uterine Cancer Diagnostic Testing Market Share by Application (2015-2020)
Table 39. Europe Key Players Uterine Cancer Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Uterine Cancer Diagnostic Testing Market Share (2019-2020)
Table 41. Europe Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Uterine Cancer Diagnostic Testing Market Share by Type (2015-2020)
Table 43. Europe Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Uterine Cancer Diagnostic Testing Market Share by Application (2015-2020)
Table 45. China Key Players Uterine Cancer Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 46. China Key Players Uterine Cancer Diagnostic Testing Market Share (2019-2020)
Table 47. China Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 48. China Uterine Cancer Diagnostic Testing Market Share by Type (2015-2020)
Table 49. China Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 50. China Uterine Cancer Diagnostic Testing Market Share by Application (2015-2020)
Table 51. Japan Key Players Uterine Cancer Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Uterine Cancer Diagnostic Testing Market Share (2019-2020)
Table 53. Japan Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Uterine Cancer Diagnostic Testing Market Share by Type (2015-2020)
Table 55. Japan Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Uterine Cancer Diagnostic Testing Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Uterine Cancer Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Uterine Cancer Diagnostic Testing Market Share (2019-2020)
Table 59. Southeast Asia Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Uterine Cancer Diagnostic Testing Market Share by Type (2015-2020)
Table 61. Southeast Asia Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Uterine Cancer Diagnostic Testing Market Share by Application (2015-2020)
Table 63. India Key Players Uterine Cancer Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 64. India Key Players Uterine Cancer Diagnostic Testing Market Share (2019-2020)
Table 65. India Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 66. India Uterine Cancer Diagnostic Testing Market Share by Type (2015-2020)
Table 67. India Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 68. India Uterine Cancer Diagnostic Testing Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Uterine Cancer Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Uterine Cancer Diagnostic Testing Market Share (2019-2020)
Table 71. Central & South America Uterine Cancer Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Uterine Cancer Diagnostic Testing Market Share by Type (2015-2020)
Table 73. Central & South America Uterine Cancer Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Uterine Cancer Diagnostic Testing Market Share by Application (2015-2020)
Table 75. Abbott Company Details
Table 76. Abbott Business Overview
Table 77. Abbott Product
Table 78. Abbott Revenue in Uterine Cancer Diagnostic Testing Business (2015-2020) (Million US$)
Table 79. Abbott Recent Development
Table 80. Roche Holdings Company Details
Table 81. Roche Holdings Business Overview
Table 82. Roche Holdings Product
Table 83. Roche Holdings Revenue in Uterine Cancer Diagnostic Testing Business (2015-2020) (Million US$)
Table 84. Roche Holdings Recent Development
Table 85. Siemens Company Details
Table 86. Siemens Business Overview
Table 87. Siemens Product
Table 88. Siemens Revenue in Uterine Cancer Diagnostic Testing Business (2015-2020) (Million US$)
Table 89. Siemens Recent Development
Table 90. Danaher Company Details
Table 91. Danaher Business Overview
Table 92. Danaher Product
Table 93. Danaher Revenue in Uterine Cancer Diagnostic Testing Business (2015-2020) (Million US$)
Table 94. Danaher Recent Development
Table 95. BioMerieux Company Details
Table 96. BioMerieux Business Overview
Table 97. BioMerieux Product
Table 98. BioMerieux Revenue in Uterine Cancer Diagnostic Testing Business (2015-2020) (Million US$)
Table 99. BioMerieux Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Uterine Cancer Diagnostic Testing Market Share by Type: 2020 VS 2026
Figure 2. Ultrasound Scanning Features
Figure 3. Biopsy Procedures Features
Figure 4. Blood Tests Features
Figure 5. Global Uterine Cancer Diagnostic Testing Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Cancer Research Institutes Case Studies
Figure 9. Specialized Clinics Case Studies
Figure 10. Diagnostic Laboratories Case Studies
Figure 11. Others Case Studies
Figure 12. Uterine Cancer Diagnostic Testing Report Years Considered
Figure 13. Global Uterine Cancer Diagnostic Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Uterine Cancer Diagnostic Testing Market Share by Regions: 2020 VS 2026
Figure 15. Global Uterine Cancer Diagnostic Testing Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Uterine Cancer Diagnostic Testing Market Share by Players in 2019
Figure 18. Global Top Uterine Cancer Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Cancer Diagnostic Testing as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Uterine Cancer Diagnostic Testing Revenue in 2019
Figure 20. North America Uterine Cancer Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Uterine Cancer Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Uterine Cancer Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Uterine Cancer Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Uterine Cancer Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Uterine Cancer Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Uterine Cancer Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed

以下、関連資料のご紹介

診療所用診断検査の世界市場（～2026年）

Global Physician Office Diagnostic Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY04269 2020年11月20日 97Pages
当調査資料は診療所用診断検査のグローバル市場について調査・分析したレポートです。種類別（血糖モニタリングキット、心臓代謝モニタリングキット、検査、感染症検査キット、凝固モニタリングキット、妊娠および生殖能力検査キット、腫瘍/癌マーカー、尿検査検査キット、コレステロール検査ストリップ）市場規模、用途別...

免疫タンパク質診断検査の世界市場（～2026年）

Global Immunoprotein Diagnostic Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY12317 2020年11月25日 96Pages
当調査資料は免疫タンパク質診断検査のグローバル市場について調査・分析したレポートです。種類別（C反応性タンパク質診断検査、補体系タンパク質診断検査、プレアルブミン診断検査、ハプトグロビン診断検査、免疫グロブリン診断検査、フリーライトチェーン診断検査、その他）市場規模、用途別（自己免疫検査、感染症検査...

骨・ミネラル診断検査の世界市場（～2026年）

Global Bone and Mineral Diagnostic Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY11156 2020年11月25日 94Pages
当調査資料は骨・ミネラル診断検査のグローバル市場について調査・分析したレポートです。種類別（機器、アッセイ/消耗品）市場規模、用途別（ビタミンD検査、骨代謝）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...

がん検診/スクリーニングの世界市場（～2026年）

Global Cancer Testing/Screening Market Size, Status and Forecast 2020-2026
MRC2-11QY11234 2020年11月25日 93Pages
当調査資料はがん検診/スクリーニングのグローバル市場について調査・分析したレポートです。種類別（肺がん、血液がん、骨がん、胆嚢がん、その他）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...

IVD（体外診断）検査の世界市場（～2026年）

Global IVD (In Vitro Diagnostic) Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY12449 2020年11月25日 92Pages
当調査資料はIVD（体外診断）検査のグローバル市場について調査・分析したレポートです。種類別（ポイントオブケア診断、免疫化学診断、臨床化学診断、分子診断、血液診断機器、微生物診断、血液診断機器、ヘモスタシス診断）市場規模、用途別（病院、外来手術センター、診断センター、その他）市場規模、地域別（北米、...

筋骨格診断検査の世界市場（～2026年）

Global Musculoskeletal Diagnostic Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY03876 2020年11月20日 92Pages
当調査資料は筋骨格診断検査のグローバル市場について調査・分析したレポートです。種類別（X線、二重エネルギーX線吸収測定法（DXA）、コンピューター断層撮影（CT）、磁気共鳴画像法（MRI）、超音波検査、その他）市場規模、用途別（病院、診療所、診断研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッ...

豚診断検査の世界市場（～2026年）

Global Swine Diagnostic Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY04773 2020年11月20日 92Pages
当調査資料は豚診断検査のグローバル市場について調査・分析したレポートです。種類別（イムノアッセイ（ELISA）キット、PCRキット、その他）市場規模、用途別（獣医病院、獣医クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、...

感染症診断検査の世界市場（～2026年）

Global Infectious Disease Diagnostic Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY12364 2020年11月25日 92Pages
当調査資料は感染症診断検査のグローバル市場について調査・分析したレポートです。種類別（分子診断検査、POC感染症診断検査）市場規模、用途別（HIV、HAI、呼吸器、熱帯病、肝臓、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

風疹診断検査の世界市場（～2026年）

Global Rubella Diagnostic Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY04539 2020年11月20日 99Pages
当調査資料は風疹診断検査のグローバル市場について調査・分析したレポートです。種類別（フローサイトメトリー、ラテックススライド凝集反応、モノクローナル抗体、イムノアッセイ、血清学的検査、臨床評価）市場規模、用途別（病院、商業、診療所、保健所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ド...

髄膜炎診断検査の世界市場（～2026年）

Global Meningitis Diagnostic Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY12651 2020年11月25日 97Pages
当調査資料は髄膜炎診断検査のグローバル市場について調査・分析したレポートです。種類別（ラテックス凝集試験、PCRアッセイ、ラテラルフローアッセイ、培養試験、ELISA試験）市場規模、用途別（病院・クリニック、診断センター、研究センター、学術医療センター）市場規模、地域別（北米、米国、カナダ、ヨーロッ...

がん検診/スクリーニングの世界市場（～2026年） Screening means checking your body for cancer before you have symptoms. In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer. Market Analysis and Insights: Global Cancer Testing/Screening Market The global Cancer Testing/Screening market…
肺がん診断検査の世界市場（～2026年） Market Analysis and Insights: Global Lung Cancer Diagnostic Tests Market The global Lung Cancer Diagnostic Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Lung Cancer Diagnostic Tests Scope and Market Size Lung C…
診療所用診断検査の世界市場（～2026年） Physician office diagnostic testing is similar to the point-of-care diagnostic testing which are carried out in physician’s office, hospital, home and others. The physician office diagnostic testing market is expected to grow at a rapid growth rate over the forecast period owing to the increasing se…
大腸がん診断の世界市場（～2026年） Fecal occult blood tests dominated the industry in 2016 owing to cost effectiveness and non-invasiveness as compared to colonoscopy and sigmoidoscopy. Immuno-FOB agglutination and Immuno-FOB ELISA tests are major revenue generating segments of fecal occult blood tests segment. Growing awareness alon…
子宮頸がん診断検査の世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Diagnostic Test Market The global Cervical Cancer Diagnostic Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…